Pfizer Inc (PFE)

47.06
-0.10(-0.21%)
  • Volume:
    3,034
  • Bid/Ask:
    47.06/47.18
  • Day's Range:
    47.06 - 47.30

PFE Overview

Prev. Close
47.16
Day's Range
47.06-47.3
Revenue
-
Open
47.12
52 wk Range
39-54.57
EPS
-
Volume
3,034
Market Cap
265.55B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
19,212
P/E Ratio
-
Beta
-
1-Year Change
-1.08%
Shares Outstanding
5,613,314,537
Next Earnings Date
31 Jan 2023
What is your sentiment on Pfizer?
or
Vote to see community's results!

Pfizer Inc News

Pfizer Inc Analysis

Pfizer Inc Company Profile

Pfizer Inc Company Profile

Employees
79000
  • Type:Equity
  • Market:Germany
  • ISIN:US7170811035
  • WKN:852009

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women’s health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Read More

Analyst Price Target

Average54.90 (+11.56% Upside)
High75
Low44
Price49.21
No. of Analysts20
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralStrong BuyBuyStrong BuyStrong Buy
Technical IndicatorsSellStrong BuyStrong BuyStrong BuyStrong Buy
SummaryNeutralStrong BuyStrong BuyStrong BuyStrong Buy
  • Still aiming for sub 40
    0
    • Great long term er at this price
      1
      • please never effective.inbox me for fast rising stocks
        0
        • Adverse Effects Rife
          0
          • No logic for drop. This is a 60 Euro stock value
            0
            • It will drop like a stone, when the FDA release the data.
              0
          • time to jump ship. New variants are weaker, hospitalisations are down, no longer a need for vaccine or meds. vaccine centres in the UK are now practically empty. It was a good two year ride, but time to bail.
            4
            • Strong buyPresident Biden has doubled commitment of the Pfizer pill treatment to at least 20 million courses as the Covid omicron variant rages.
              0
              • Why TF is this not rising ?
                0
                • The Covid Detector device has been added to the Register of rapid tests for the detection of SARS-CoV-2 virus in Austria. This instant contactless detector from ML System
                  0
                  • Rumors says Albert have been arrested this Friday is it true or fraud? Anybody knows?
                    7